Average Co-Inventor Count = 5.88
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Elucid Bioimaging Inc. (20 from 39 patents)
2. Elucid Bioiwaging Inc. (1 from 1 patent)
21 patents:
1. 12236595 - Characterizing permeability, neovascularization, necrosis, collagen breakdown, or inflammation
2. 12229957 - Systems and methods for diagnostics for management of cardiovascular disease patients
3. 12159406 - Determining biological properties of atherosclerotic plaque, coronary artery disease, or vasculopathy
4. 12141975 - Myocardial ischemia prediction
5. 12136214 - Non-invasive imaging to inform patient care
6. 12131471 - Longitudinal change measures for optimizing patient care
7. 12131472 - Non-invasive imaging to determine health and disease
8. 12106477 - Segmenting permeability, neovascularization, necrosis, collagen breakdown, or inflammation to characterize atherosclerotic plaque, coronary artery disease, or vasculopathy
9. 12073561 - Multiscale modeling to determine molecular profiles from radiology
10. 12045983 - Functional measures of stenosis significance
11. 12039765 - Systems and methods for optimizing analysis of CT angiography
12. 11676359 - Non-invasive quantitative imaging biomarkers of atherosclerotic plaque biology
13. 11607179 - Non-invasive risk stratification for atherosclerosis
14. 11120312 - Quantitative imaging for cancer subtype
15. 11113812 - Quantitative imaging for detecting vulnerable plaque